<DOC>
	<DOCNO>NCT01283958</DOCNO>
	<brief_summary>Identification pathophysiology associate Eisenmenger 's syndrome lead evaluation target therapy . Iloprost , prostacyclin analogue , one target therapy use patient Eisenmenger 's syndrome . The purpose study assess effect inhale iloprost patient Eisenmenger 's syndrome .</brief_summary>
	<brief_title>The Effects Inhaled Iloprost Congenital Heart Disease With Eisenmenger Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Eisenmenger Complex</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>patient Eisenmenger 's syndrome diagnose right side cardiac catheterization</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Iloprost , Eisenmenger 's syndrome</keyword>
</DOC>